Loading…
SMS Pharmaceuticals (SMSPHARMA)₹513.20+1.62%Pharmaceuticals
At the end of the Jun 2026 quarter, SMS Pharmaceuticals' shareholders were: promoters 68.06%, FIIs 0.65%, DIIs 2.84%, public 28.45%. Promoter holding is unchanged on the quarter. FII holding is up 0.62 percentage points from 0.03% a year earlier. 18.05% of promoter shares were pledged. It had 31,491 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 64.31% | 64.31% | 64.66% | 64.66% | 64.66% | 64.66% | 66.26% | 66.26% | 68.06% | 68.06% | 68.06% | 68.06% |
| FIIs | 0.60% | 0.59% | 0.17% | 0.18% | 0.52% | 0.31% | 0.08% | 0.03% | 0.28% | 0.04% | 0.31% | 0.65% |
| DIIs | 0.00% | 0.00% | 1.99% | 2.14% | 2.56% | 2.56% | 2.44% | 3.04% | 2.89% | 3.22% | 3.03% | 2.84% |
| Public | 35.09% | 35.10% | 33.18% | 33.02% | 32.26% | 32.47% | 31.22% | 30.67% | 28.77% | 28.68% | 28.60% | 28.45% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 18.05% |
| Number of shareholders | 25,247 | 25,342 | 30,142 | 31,782 | 33,138 | 34,975 | 35,334 | 33,654 | 34,159 | 34,380 | 32,399 | 31,491 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Ramesh Babu Potluri | Promoter | 19.39% | 0.00 |
| Vamsi Krishna Potluri | Promoter | 16.86% | 0.00 |
| Hima Bindu Potluri | Promoter | 15.97% | 0.00 |
| Potluri Infra Projects Llp | Promoter | 9.46% | 0.00 |
| Trilok Potluri | Promoter | 5.00% | 0.00 |
| Quant Mutual Fund - Quant Small Cap Fund | DII | 2.82% | −0.15 |
| Aniruddh Mundra | Public | 2.02% | New |
| Venkata Subbaraju Penmatsa HUF | Public | 1.83% | 0.00 |
| Sudeepthi Gopineedi | Public | 1.42% | 0.00 |
| Venkata Praveen Talluri | Public | 1.40% | 0.00 |
| Potluri Laboratories Private Limited | Promoter | 1.21% | 0.00 |
| Tvt Infracon Llp | Promoter | 0.11% | 0.00 |
| Vivek Mundra | Public | Exited | — |
Promoters held 68.06% of SMS Pharmaceuticals at the end of the Jun 2026 quarter, up 1.80 percentage points from 66.26% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.65% (up 0.34 percentage points from 0.31% a quarter earlier) and domestic institutions (DIIs) held 2.84% (down 0.19 percentage points from 3.03% a quarter earlier).
Yes. 18.05% of promoter shares were pledged at the end of the Jun 2026 quarter.
SMS Pharmaceuticals had 31,491 shareholders at the end of the Jun 2026 quarter, against 33,654 a year earlier.
Quant Mutual Fund - Quant Small Cap Fund (DII) held 2.82% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.